{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:57:46Z","timestamp":1793030266315,"version":"4.5.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Fibrotic interstitial lung diseases (ILDs) result from excessive deposition of extracellular matrix (ECM) proteins in the lung, causing irreversible damage to the lung architecture. Clinical management of ILDs differs depending on the diagnosis, but differentiation between subtypes can be difficult and better clinical biomarkers are needed. In this study, we use a 166-gene NanoString assay to investigate whether there are ILD subtype-specific transcripts in whole blood. We identified one transcript, killer cell lectin like receptor 1 (<jats:italic>KLRF1<\/jats:italic>), as differentially expressed between idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated ILD (SSc-ILD), and identified two transcripts (<jats:italic>VCAN<\/jats:italic>, <jats:italic>LTK<\/jats:italic>) associated with IPF expression against other ILD subtypes. These findings were validated by examining their expression in ILD lung, with <jats:italic>KLRF1<\/jats:italic> expression significantly higher in SSc-ILD compared to IPF and hypersensitivity pneumonitis (HP) samples. Taken together, this pilot study provides support for the use of the peripheral transcriptome in identifying diagnostic biomarkers of ILD with biological relevance.<\/jats:p>","DOI":"10.1371\/journal.pone.0314876","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:31:59Z","timestamp":1733250719000},"page":"e0314876","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic potential of genomic blood biomarkers of pulmonary fibrosis in a prospective cohort"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-6036","authenticated-orcid":true,"given":"Daniel","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-3156","authenticated-orcid":true,"given":"Casey P.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Ask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-1581","authenticated-orcid":true,"given":"Scott J.","family":"Tebbutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"10309","key":"pone.0314876.ref001","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(21)01961-9","article-title":"Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?","volume":"398","author":"EA Renzoni","year":"2021","journal-title":"The Lancet"},{"issue":"9","key":"pone.0314876.ref002","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S2213-2600(21)00017-5","article-title":"Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities","volume":"9","author":"P Spagnolo","year":"2021","journal-title":"The Lancet Respiratory Medicine"},{"issue":"3","key":"pone.0314876.ref003","doi-asserted-by":"crossref","first-page":"2101181","DOI":"10.1183\/13993003.01181-2021","article-title":"Biomarker signatures for progressive idiopathic pulmonary fibrosis","volume":"59","author":"B Clynick","year":"2022","journal-title":"Eur Respir J"},{"issue":"3","key":"pone.0314876.ref004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1164\/rccm.202110-2296OC","article-title":"The Proteomic Profile of Interstitial Lung Abnormalities","volume":"206","author":"GT Axelsson","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0314876.ref005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2213-2600(21)00503-8","article-title":"Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis","volume":"10","author":"WS Bowman","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"205","key":"pone.0314876.ref006","article-title":"Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis","volume":"5","author":"JD Herazo-Maya","year":"2013","journal-title":"Sci Transl Med"},{"issue":"11","key":"pone.0314876.ref007","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S2213-2600(17)30349-1","article-title":"Validating a 52-gene risk profile for outcome prediction in Idiopathic Pulmonary Fibrosis: an international multicentre cohort study","volume":"5","author":"JD Herazo-Maya","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"6","key":"pone.0314876.ref008","doi-asserted-by":"crossref","first-page":"e37708","DOI":"10.1371\/journal.pone.0037708","article-title":"The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis","volume":"7","author":"IV Yang","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"pone.0314876.ref009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/rccm.202008-3093OC","article-title":"Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells","volume":"204","author":"Y Huang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0314876.ref010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/thoraxjnl-2020-214790","article-title":"Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis","volume":"77","author":"ER Fern\u00e1ndez P\u00e9rez","year":"2022","journal-title":"Thorax"},{"issue":"4","key":"pone.0314876.ref011","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/rccm.201701-0110OC","article-title":"Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response","volume":"197","author":"A Singh","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"pone.0314876.ref012","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14728222.2022.2114897","article-title":"The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1\/Th2 imbalance","volume":"26","author":"P Spagnolo","year":"2022","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"pone.0314876.ref013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chest.2020.02.009","article-title":"Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis: A Multicenter Retrospective Cohort Study","volume":"158","author":"T Zaman","year":"2020","journal-title":"Chest"},{"issue":"5","key":"pone.0314876.ref014","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"G Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0314876.ref015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"G Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0314876.ref016","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1521-4141(200002)30:2<568::AID-IMMU568>3.0.CO;2-Y","article-title":"Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis","volume":"30","author":"P Roda-Navarro","year":"2000","journal-title":"Eur J Immunol"},{"issue":"2","key":"pone.0314876.ref017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","article-title":"NKp80 Defines a Critical Step during Human Natural Killer Cell Development","volume":"16","author":"AG Freud","year":"2016","journal-title":"Cell Rep"},{"issue":"7","key":"pone.0314876.ref018","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1002\/cam4.5579","article-title":"KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer","volume":"12","author":"N Mukherjee","year":"2023","journal-title":"Cancer Medicine"},{"issue":"1","key":"pone.0314876.ref019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4","article-title":"Identification of NKp80, a novel triggering molecule expressed by human NK cells","volume":"31","author":"M Vitale","year":"2001","journal-title":"Eur J Immunol"},{"issue":"4","key":"pone.0314876.ref020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","article-title":"Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity","volume":"125","author":"M Horikawa","year":"2005","journal-title":"J Invest Dermatol"},{"key":"pone.0314876.ref021","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2018.01665","article-title":"Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release","volume":"9","author":"A Benyamine","year":"2018","journal-title":"Front Immunol"},{"key":"pone.0314876.ref022","article-title":"NK Cells in Autoimmune Diseases: Protective or Pathogenic?","author":"M Liu","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"pone.0314876.ref023","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/039463200501800314","article-title":"Natural killer cells in Bal and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF)","volume":"18","author":"I Esposito","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"pone.0314876.ref024","doi-asserted-by":"crossref","first-page":"108827","DOI":"10.1016\/j.clim.2021.108827","article-title":"Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases","volume":"230","author":"L Bergantini","year":"2021","journal-title":"Clinical Immunology"},{"issue":"5","key":"pone.0314876.ref025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.202012-4418LE","article-title":"Reduced Proportion and Activity of Natural Killer Cells in the Lung of Patients with Idiopathic Pulmonary Fibrosis","volume":"204","author":"T Cruz","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0314876.ref026","doi-asserted-by":"crossref","first-page":"L887","DOI":"10.1152\/ajplung.00451.2020","article-title":"The Idiopathic Pulmonary Fibrosis Cell Atlas","volume":"319","author":"N Neumark","year":"2020","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"pone.0314876.ref027","doi-asserted-by":"crossref","first-page":"108454","DOI":"10.1016\/j.clim.2020.108454","article-title":"Circulating dendritic cells are severely decreased in idiopathic pulmonary fibrosis with a potential value for prognosis prediction","volume":"215","author":"D Galati","year":"2020","journal-title":"Clin Immunol"},{"issue":"6","key":"pone.0314876.ref028","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1164\/ajrccm.154.6.8970376","article-title":"Proteoglycan deposition in pulmonary fibrosis","volume":"154","author":"ES Bensadoun","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0314876.ref029","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12931-018-0779-y","article-title":"A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia","volume":"19","author":"JMB Sand","year":"2018","journal-title":"Respiratory Research"},{"issue":"4","key":"pone.0314876.ref030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/resp.13442","article-title":"Lumpers versus splitters: What to do with suspected idiopathic pulmonary fibrosis?","volume":"24","author":"CJ Ryerson","year":"2019","journal-title":"Respirology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:32:10Z","timestamp":1733250730000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314876"}},"subtitle":[],"editor":[{"given":"Yoshiaki","family":"Zaizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0314876","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}